Role of Neoadjuvant Chemotherapy Followed by Interval Cyto-Reductive Surgery in Reducing Progression and Recurrence of Patients with Advanced Endometrial Cancer - Egyptian Knowledge Bank - troweb

279925

Role of Neoadjuvant Chemotherapy Followed by Interval Cyto-Reductive Surgery in Reducing Progression and Recurrence of Patients with Advanced Endometrial Cancer

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

Role of Pelvic and Para-Aortic Lymphadenectomy in Advanced Ovarian Epithelial Cancer

Article

Interval debulking Surgery after Neoadjuvant Chemotherapy for Advanced Ovarian Carcinoma, Impact on Patients’ Survival

Article

ADVANCED EPITHELIAL OVARIAN CANCER: THE PROGNOSTIC SIGNIFICANCE OF RESIDUAL DISEASE AFTER CYTOREDUCTIVE SURGERY

Article

A Prospective Study of Adjuvant Radiotherapy Concomitant with Cisplatin Followed by Paclitaxel-Carboplatin in High Risk Early Stage Endometrial Cancer

Article

Evaluation of the role of neoadjuvant chemotherapy in the management of rectal cancer

Article

Comparative study between preoperative and operative staging in endometrial cancer patients

Article

Concurrent Chemoradiation versus Radiotherapy Alone in Adjuvant Setting for High-Risk Endometrial Carcinoma

Article

ROLE OF UPFRONT SURGERY IN ADVANCED ENDOMETRIAL CANCER AT EL SHATBY MATERNITY UNIVERSITY HOSPITAL

Article

Prognostic Significance of Systematic Lymphadenectomy as Part of Primary Debulking Surgery in Patients with Ovarian Cancer

Article

ROLE OF ROUTINE COMPREHENSIVE SYSTEMATICPELVIC LYMPHADENECTOMY IN THE MANAGEMENT OF ENDOMETRIAL CANCER: A RETROSPECTIVE COHORT STUDY